Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
National Healthcare's revenue for the
three
months ended in Jun. 2026 was €354 Mil.
Its revenue for the trailing twelve months (TTM) ended in Jun. 2026 was €1,341 Mil.
National Healthcare's Revenue per Share for the
three
months ended in Jun. 2026 was €22.33.
Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was €85.04.
During the past 12 months, the average Revenue per Share Growth Rate of National Healthcare was 6.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 11.70% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 8.60% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 3.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, National Healthcare's highest 3-Year average Revenue per Share Growth Rate was 11.70% per year. The lowest was -3.60% per year. And the median was 3.10% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
National Healthcare Revenue Related Terms
National Healthcare Revenue Historical Data
* Premium members only.
The historical data trend for National Healthcare's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, National Healthcare's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
National Healthcare Revenue vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, National Healthcare's Revenue distribution charts can be found below:
* The bar in red indicates where National Healthcare's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,341 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
National Healthcare (FRA:HTW) has a Revenue of €1,341 Mil as of Jun. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on National Healthcare and its competitors.
Is National Healthcare's Revenue too high?
National Healthcare's current Revenue is €1,341 Mil. Overall, National Healthcare has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does National Healthcare's Revenue compare to BKD and OPCH?
National Healthcare's Revenue of €1,341 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on National Healthcare and its competitors. National Healthcare's current Revenue is €1,341 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is National Healthcare stock overvalued right now?
National Healthcare (FRA:HTW) has a current Revenue of €1,341 Mil. The stock's GF Value™ is €111.35, compared to a current price of €186.00 — trading 67% above its estimated fair value. The current Revenue is €1,341 Mil. National Healthcare's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For National Healthcare (FRA:HTW), the current Revenue is €1,341 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is National Healthcare (FRA:HTW) Overvalued in 2026?
Based on GuruFocus' analysis, National Healthcare stock appears to be overvalued.
The current stock price of €186.00 is trading 67% above its estimated GF Value™ of €111.35.
Key valuation signals for FRA:HTW:
Revenue: €1,341 Mil
GF Value™: €111.35 vs. price of €186.00 (67% above fair value)
No single metric tells the full story. See the FRA:HTW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.
71GF Score
Get the complete analysis for FRA:HTW
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:HTW has been successfully added to your 
